Cancer: Medical Treatments
Lords · Question HL7769 · Tabled 21 May 2025 · Department of Health and Social Care · Official record
Answered 9 Jun 2025
Question
Asked by Lord Markham
To ask His Majesty's Government what steps they are taking to measure the effectiveness of and potential to rapidly adopt cancer therapies that require non-genomic biomarker testing.
Answer
Answered by Baroness Merron, 9 Jun 2025
The Medicines and Healthcare products Regulatory Agency (MHRA) has a key role in assessing the safety and efficacy of any medicine, and newly licensed medicines are appraised by the National Institute for Health and Care Excellence (NICE).The NICE routine...